<dd id="uxuck"><noscript id="uxuck"></noscript></dd>
  • <tbody id="uxuck"></tbody>

    <rp id="uxuck"><acronym id="uxuck"></acronym></rp>
    <progress id="uxuck"></progress><button id="uxuck"><acronym id="uxuck"></acronym></button>
  • <s id="uxuck"><object id="uxuck"></object></s>
  • <button id="uxuck"><object id="uxuck"></object></button>

    <button id="uxuck"><acronym id="uxuck"></acronym></button>
    <em id="uxuck"><ruby id="uxuck"><input id="uxuck"></input></ruby></em><button id="uxuck"></button><li id="uxuck"><acronym id="uxuck"></acronym></li>
    <rp id="uxuck"><object id="uxuck"><input id="uxuck"></input></object></rp>

    中文 EN

    About Us

    Amoytop Biotech is an innovative biopharmaceutical company in China, specialized in R&D, manufacturing and marketing of regular and long-acting recombinant protein drugs. Focusing on the R&D of immune-related cytokine medicines, Amoytop Biotech is committed to providing better solutions for major diseases including viral hepatitis, malignant tumors and immunotherapy. In the future, Amoytop Biotech will specially focus on CHB (chronic hepatitis B) treatment to achieve breakthroughs in clinical cure.

    PRODUCT

    01

    Peginterferon Alfa-2b

    Pegylated Recombinant Human Interferon alfa-2b

    1st?40kD Y-shape branched PEG modified interferon alfa-2b injection

    02

    Molgramostim

    Recombinant Human Granulocyte Macrophage Colony-Stimulating Factor

    National Medical Insurance, Category B ; Launched in 1997,The first China-made Molgramostim in marke

    03

    Filgrastim

    Recombinant Human Granulocyte Colony-Stimulating Factor

    National Medical Insurance, Category B;Launched in 1999 and awarded as an excellent brand of biologi

    04

    Oprelvekin

    Recombinant Human Interleukin 11

    National Medical Insurance, Category B;?Launched in 2005,,National standard bulk supplier of rHuIL-1

    INNOVATING

    Research and Innovation

    Committing to research and innovation of recombinant protein medicines, especially long-acting modification, Amoytop Biotech has established its own research teams and systems that composed of following modules: R&D center, medical development center, manufacturing center and quality center, covering all R&D aspects of innovative medicines from scientific discovery, laboratory trial, pilot trial, preclinical and clinical trial to industrialization. All modules are run and connected through Core Technology Platform and projectization, forming a complete closed loop for R&D cycle.

    CONTACT US

    Xiamen Amoytop Biotech Co., Ltd.

    • Tel:86 592 6889105/108

      Email: bd.amoytop@gmail.com / international@amoytop.com

      Add:No. 330 Wengjiao Road, Haicang, Xiamen, Fujian, China

      Postcode:361028

    • Join Us:0592-7701210

      Email:hr@amoytop.com

    • Adverse Events Tel:86-592-6889111

      Adverse Events Email:fk@amoytop.com

    囯产精品一区二区免费在线观看_久久久久国色AV免费观看下载_成人av一区二区电影在线观看_国产激情91无码视频一区
    <dd id="uxuck"><noscript id="uxuck"></noscript></dd>
  • <tbody id="uxuck"></tbody>

    <rp id="uxuck"><acronym id="uxuck"></acronym></rp>
    <progress id="uxuck"></progress><button id="uxuck"><acronym id="uxuck"></acronym></button>
  • <s id="uxuck"><object id="uxuck"></object></s>
  • <button id="uxuck"><object id="uxuck"></object></button>

    <button id="uxuck"><acronym id="uxuck"></acronym></button>
    <em id="uxuck"><ruby id="uxuck"><input id="uxuck"></input></ruby></em><button id="uxuck"></button><li id="uxuck"><acronym id="uxuck"></acronym></li>
    <rp id="uxuck"><object id="uxuck"><input id="uxuck"></input></object></rp>